A. Minami

发表

Combination effect of recombinant human interleukin-1 alpha with antimicrobial agents

S. Nakamura, T. Kojima, K. Fujimoto, 1989, Antimicrobial Agents and Chemotherapy.

Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha

K. Fujimoto, S. Nakamura, A. Minami, 1988, Infection and immunity.

Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a

T. Ōhashi, S. Nakamura, A. Minami, 1987, Infection and immunity.

Combination Effect of Recombinant Human Interleukin-loL with Antimicrobial Agents

S. Nakamura, T. Kojima, A. Minami, 2022 .

Pipemidic Acid, a New Antibacterial Agent Active Against Pseudomonas aeruginosa: In Vitro Properties

H. Katae, Y. Kubo, S. Inoue, 1975, Antimicrobial Agents and Chemotherapy.

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

S. Kashimoto, T. Ohue, S. Nakamura, 1989, Antimicrobial Agents and Chemotherapy.

Synthesis and Biological Activities of N-Acetylglucosaminyl-β(1→4)-N-Acetylmuramyl Tri- and Tetrapeptide Derivatives

S. Kotani, S. Naruto, S. Kawata, 1986 .

PIPEMIDIC ACID , A NEW ANTIBACTERIAL AGENT Organism Streptococcus hemolyticus Diplococcus pneumoniae Corynebacterium pyogenes Erysipelothrix rhusiopathiae Haemophilus influenzae Neisseria meningitidis

H. Katae, Y. Kubo, S. Inoue, 2022 .

In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid

H. Katae, S. Inoue, J. Yamagishi, 1983, Antimicrobial Agents and Chemotherapy.

Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice

H. Katae, S. Kashimoto, J. Yamagishi, 1983, Antimicrobial Agents and Chemotherapy.

Pipemidic Acid: Its Activities Against Various Experimental Infections

H. Katae, K. Nakata, Shinichi Nakamura, 1976, Antimicrobial Agents and Chemotherapy.